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Low diagnostic accuracy of selective screening
criteria for asymptomatic Chlamydia trachomatis
infections in the general population
Irene G M van Valkengoed, Servaas A Morré, Adriaan J C van den Brule,
Chris J L M Meijer, Walter Devillé, Lex M Bouter, A Joan P Boeke
Objectives: To develop and validate selective screening criteria for asymptomatic Chlamydia tra-
chomatis infections in the general population.
Methods: 11 505 people, aged 15–40 years, registered in 16 general practices in Amsterdam
were invited to return by mail a home obtained first void urine sample and a questionnaire. Par-
ticipants were randomly allocated into a development group (75%) or a validation group (25%).
C trachomatis infection was determined by the ligase chain reaction. In the development group a
set of criteria was identified by means of stepwise logistic regression analysis. The diagnostic
accuracy (area under the ROC curve; AUC) and sensitivity, and the corresponding percentage of
people selected for screening were calculated. The criteria developed in this study were applied
to the validation group.
Results: The prevalence of asymptomatic C trachomatis infections among men was found to be
2.4% (1.7–3.0), and among women 2.8% (2.2–3.4). Screening men, based on Surinam/Antillean
origin and painful micturition, yielded an AUC of 0.58 (0.55–0.60). Screening women, based on
Surinam/Antillean origin, new sex partner in the previous 2 months, and unmarried/not cohabit-
ing, yielded an AUC of 0.67 (0.65–0.69). Application of the criteria for men to the validation
group yielded an AUC of 0.53 (0.48–0.57); by screening 10% of the men, 15% of the cases were
detected. The AUC of the criteria for women in the validation group was 0.58 (0.54–0.61); by
screening 51% of the women, 63% of the cases were detected.
Conclusion:The prevalence of asymptomatic C trachomatis infections in Amsterdam is less than
3%. No suitable selective screening criteria for the general population could be identified.
(Sex Transm Inf 2000;76:375–380)
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Introduction
Genital infections caused Chlamydia trachoma-
tis are the most prevalent sexually transmitted
infections in the Netherlands, as well as in
other industrialised countries.1 Since genital
chlamydial infection causes no or few symp-
toms, many infections remain undetected. An
untreated infection in women may lead to pel-
vic inflammatory disease (PID), and at a later
stage to infertility, ectopic pregnancy, and
chronic abdominal pain.2 Infected women can
pass the infection on to their children at birth.3
Complications in men are less severe. Screen-
ing and treatment is indicated for men in order
to prevent the infection from spreading.
Scholes et al have shown that screening for
asymptomatic infections in women results in a
reduction of 56% in the incidence of PID.4 In
the past, most screening programmes have
been opportunistic, focusing on patients at-
tending healthcare clinics or specific high risk
groups. The introduction of sensitive DNA
detection methods to test non-invasively col-
lected specimens, such as urine,5 6 and the use
of mailed home obtained samples makes it
possible to extend screening beyond the
traditional settings.7 8
The eYciency of screening strongly depends
on the prevalence of infections in the target
population, and there is still a lack of estimates
of the prevalence of asymptomatic infections in
the general population. In inner city practices
in London, a prevalence of 2.6% was found
among sexually active women who were due for
a routine health check up. Selective screening
has been suggested as an eYcient strategy,
since universal screening may not be appropri-
ate in a low prevalence population.9 Selective
screening criteria for women have been sug-
gested in various other studies. However, most
of these criteria were derived from opportunis-
tic or clinic based screening programmes, and
may not be applicable in screening a general
population. Furthermore, these criteria have
seldom been evaluated in a population, other
than that from which the criteria were derived,
although the performance of these criteria in
the development group is typically too
optimistic.10–17 No selective screening criteria
for men have yet been evaluated.
The objective of this study was to develop
and validate selective screening criteria for a
population based screening for asymptomatic
C trachomatis infections in an inner city
population.
Methods
POPULATION
A random sample of 5791 men and 5714
women, aged 15–40 years, was selected from
the computer registers of 16 inner city general
practices in Amsterdam. All practices were
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selected based on previous research experience
with the institute. The practices were spread
throughout the city such that all districts of
Amsterdam were represented in the study.
RECRUITMENT
Between March 1996 and November 1997 all
patients who were selected for the sample
received an invitation from their own general
practitioner explaining the purpose of the
study. Included with the letter was a card which
could be returned if the patient was unwilling
to participate. A urine container and a
questionnaire were also sent to the home
address of potential participants. To ensure
anonymity, all materials were coded. Patients
were requested to collect a first void, first
stream urine sample and to complete the ques-
tionnaire. The questionnaire contained 29
(women) or 22 (men) open and closed
questions on demographic variables, current
urogenital symptoms, history of sexually trans-
mitted diseases, and sexual behaviour. All
information material and the demographic
questions on the questionnaire were translated
into the most relevant languages in
Amsterdam—Dutch, English, Arabic, and
Turkish. Patients were requested to return the
urine samples and the questionnaire to the
Department of Pathology in a prestamped
addressed envelope, which was included in the
material. Non-respondents were sent one
single reminder 3 weeks after the material was
mailed to them. At the end of the study, a non-
participants study was also carried out. Every
practice was requested to supply information
on age, marital status, type of health insurance,
and ethnic origin for 50 randomly chosen non-
participants. Moreover, practitioners were re-
quested to check whether the address listed in
the computer register at the start of the study
was correct.
The study has been approved by the medical
ethics committee of the Vrije Universiteit in
Amsterdam.
DETECTION OF C TRACHOMATIS
Urine samples were tested for the presence of C
trachomatis DNA by means of the ligase chain
reaction (LCR) (Abbott Laboratories, Chi-
cago, IL, USA) in the laboratory of the depart-
ment of pathology of the University Hospital
Vrije Universiteit. Tests were performed ac-
cording to the instructions of the manufac-
turer, and the results of the tests were sent back
to the practice in which the patient was
registered. The general practitioners were
instructed to treat infected patients with a sin-
gle dose of 1000 mg azithromycin, or erythro-
mycin for pregnant women (4 ×500 mg for 5
days), and to notify the partners.
STATISTICAL ANALYSIS
Development of the screening criteria
Participants were randomly allocated into a
development group and a validation group
(75% and 25% of the participants, respec-
tively). Participants who reported that they had
never been sexually active were excluded from
further analysis, since they were not at risk for
the infection.
For the development group, univariate logis-
tic regression analyses were performed, with
self reported characteristics as independent
variables and chlamydia diagnosis as the
dependent variable. Variables showing an
association of p<0.25 for the Wald test were
included in the multivariate analysis. If more
than one variable measuring the same concept
showed such an association, the variable which
showed the strongest association was selected.
In the next stage, a forward stepwise logistic
regression analysis was performed. Criteria for
entry into the model and elimination from the
model were a p value for the likelihood ratio
test of 0.05 and 0.08, respectively. In the
resulting models, interaction terms were taken
into consideration, but only those interaction
terms that significantly improved the model
were included. All logistic regression analyses
were performed with the SPSS package version
7.5.2.
Subsequently, the probability of a C tracho-
matis infection was calculated, using the
formula:
where p(C trachomatis) is the probability of
infection, a is the constant, and B represents
the regression coeYcient for every determinant
interaction term x. Using the predicted prob-
abilities, a receiver operator characteristic
(ROC) curve, a plot of the sensitivity against 1
− specificity, was constructed in MEDCALC, ver-
sion 4.20.021 (F Schoonjans, Belgium). The
calculated area under the ROC curve (AUC) is
a measure of the diagnostic accuracy: the
chance of correctly classifying a randomly
selected couple of positive/negative observa-
tions, irrespective of the cut oV value for posi-
tivity. An AUC of less than 0.60 was considered
to be poor, 0.60–0.75 was moderate, and
higher than 0.75 was good.
To ensure detection of a suYcient number of
cases, a cut oV point was chosen for each
model, at which the calculated sensitivity was
close to 80%. The sensitivity, the percentage of
the total population selected for screening (true
positive fraction plus the false positive frac-
tion), and the prevalence in the screened popu-
lation (predictive value positive) were calcu-
lated at this cut oV point.
A multilevel analysis was performed, using
the MLWIN program version 1.02.0002, to
account for variance at the level of general
practice.
Validation of the model
The probability of infection for all patients in
the validation group was calculated on the basis
of the estimates of the coeYcients for the
model found in the development group.18 The
AUC was calculated, and the sensitivity and
the percentage of the population screened were
determined at the same cut oV value as chosen
for the development group.
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Results
PARTICIPATION AND PREVALENCE
The overall participation rate among women
was 51%, and among men 33%; 104 samples
and questionnaires were excluded from analy-
sis because the respondent was not selected for
the study sample, four other patients were
excluded because they provided insuYcient
urine.
Of the non-participants, 9% indicated on the
postcard enclosed in the invitation that they
were unwilling to participate. The question-
naire concerning non-participants was com-
pleted by 12 of the 16 practices. Other
practices were unwilling to supply additional
information about men and women who had
(indirectly) declined to participate in the study,
by not returning the questionnaire or sample.
After the study commenced, it was found
that 18% of the non-participants no longer
lived at the address listed in the computer reg-
ister at the start of the study. Participants were
more frequently of Dutch origin than non-
participants (table 1). Age, marital status, and
type of health insurance were similar in both
groups.
The overall prevalence of asymptomatic C
trachomatis infections in women was 2.8%
(2.2–3.4). The highest infection rates were
found in women who were 21–25 years of age
and in women who were of Surinam or
Antillean origin. Among men the prevalence
was 2.4% (1.7–3.0). The highest infection rates
were found in men who were 21–30 years of
age and among men who were of Surinam or
Antillean origin (table 2).
In all, 125 women and 121 men reported
that they had never had sexual contact, and
were excluded from the analysis of selective
screening criteria. Of these patients 65% were
under 25 years of age.
DEVELOPMENT OF THE SCREENING CRITERIA
(DEVELOPMENT GROUP)
Determinants associated with chlamydial in-
fection in men and women according to
univariate analysis (p<0.25) are shown in table
3. Determinants showing the strongest associ-
ation with infections among sexually active
women were Surinam or Antillean origin, age
<25 years, unmarried and not cohabiting,
heavy vaginal discharge, and a new sex partner
in the previous 2 months. Years of education,
type of health insurance, lifetime number of sex
partners, inconsistent condom use, vaginal
douching, intermenstrual bleeding, blood loss
after sexual intercourse, foul smelling dis-
charge, painful or frequent micturition, and
history of sexually transmitted infections
showed no association at a level of p<0.25
(data not shown).
Factors most strongly associated with the
presence of an infection in sexually active men
were Surinam or Antillean origin, more than
15 years of education and urethral discharge.
Unmarried and not cohabiting, type of health
insurance, frequent micturition, heterosexual-
ity, and inconsistent condom use showed no
association at a level of p<0.25 (data not
shown).
Table 1 Characteristics of participants and non-participants in a screening programme for
asymptomatic Chlamydia trachomatis infections by means of mailed, home obtained urine
specimens
Characteristic
Prevalence of characteristic (%)
Non-participants
(n=548†)
Participants*
(n=3368)
Age (years) NS
15–20 9.6 8.2
21–25 13.6 16.2
26–30 24.5 26.7
31–35 30.2 26.8
36–40 22.2 22.1
Origin p<0.001‡
Dutch 60.1 75.0
Other European 4.8 3.2
Surinam/Antillean 11.6 10.8
Turkish/Moroccan 13.8 5.4
Other 9.6 5.5
Married or cohabiting NS
Yes 45.5 48.3
No 54.5 51.7
Type of health insurance NS
Government 73.1 72.9
Private 26.9 27.1
*Participants from practices that supplied information on non-participants.
†Information on two people was not supplied by practices.
‡÷2 test.
Table 2 Prevalence of asymptomatic Chlamydia trachomatis infections as detected by
ligase chain reaction in urine, in men and women registered in inner city general practices in
Amsterdam; total prevalence, prevalence according to age, and prevalence according to
origin
Females Males
Cases/n
Prevalence (%)
[95% CI] Cases/n
Prevalence (%)
[95% CI]
Total 81/2902 2.8 [2.2–3.4] 45/1908 2.4 [1.7–3.0]
Age (years)
15–20 5/209 2.4 [0.3–4.5] 1/149 0.7 [0–2.0]
21–25 21/472 4.4 [2.6–6.3] 8/246 3.3 [1.0–5.5]
26–30 23/832 2.8 [1.6–3.9] 15/476 3.2 [1.6–4.7]
31–35 19/756 2.5 [1.4–3.6] 14/575 2.4 [1.2–3.7]
36–40 13/632 2.1 [0.9–3.1] 7/462 1.5 [0.4–2.6]
Origin
Dutch 59/2204 2.7 [2.0–3.4] 30/1368 2.2 [1.4–3.0]
Other European 3/104 2.9 [0–6.1] 1/62 1.6 [0–4.8]
Surinam/Antillean 15/294 5.1 [2.6–7.6] 9/162 5.6 [2.0–9.1]
Turkish/Moroccan 1/114 0.9 [0–2.6] 3/148 2.0 [0–4.3]
Other 2/125 1.6 [0–3.8] 2/122 1.6 [0–3.9]
CI = confidence interval.
Table 3 Determinants of infection with Chlamydia trachomatis for men and women in the
development group (75% of all participants) selected for the multivariate analysis*
Sex Determinant
Prevalence determinant (%)
OR [95% CI]Cases Non-cases
Female Number 62 2178
Age <25 33.3 21.5 1.87 [1.08–3.23]
Surinam or Antillean origin 20.3 10.1 2.35 [1.22–4.50]
Unmarried and not cohabiting 71.2 47.6 2.79 [1.58–4.95]
Heterosexual† 98.3 93.9 3.92 [0.54–28.51]
Sexual debut <18 years 90.0 54.8 0.67 [0.40–1.12]
New sex partner 21.7 8.5 3.12 [1.67–5.89]
Lower abdominal pain 11.9 18.2 0.59 [0.27–1.33]
Coloured discharge 20.3 14.3 1.55 [0.81–2.96]
Heavy vaginal discharge 35.0 21.7 1.99 [1.16–3.41]
Male Number 32 1438
Age <30 54.8 43.6 1.58 [0.78–3.25]
Surinam or Antillean origin 54.8 9.3 2.97 [1.25–7.06]
Government health insurance 61.3 70.3 0.66 [0.31–1.38]
>15 years of education 72.4 54.9 2.19 [0.96–4.98]
Sexual debut <18 years 66.7 52.3 1.85 [0.86–3.98]
>5 lifetime sex partners 71.4 57.8 1.85 [0.81–4.24]
Previous C trachomatis
infection 10.3 4.9 2.31 [0.68–7.85]
Urethral discharge 6.5 1.9 3.69 [0.83–16.39]
Painful micturition 6.5 2.6 2.73 [0.62–11.96]
*Only determinants selected for the multivariate analysis, based on a Wald test for univariate
association of p<0.25, are shown.
†Was not included in the final analysis, because there was only one homo/bisexual women with a
C trachomatis infection.
OR = odds ratio, CI = confidence interval.
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Results of the multivariate analyses are
presented in table 4. The model for women was
based on Surinam or Antillean origin, a new
sex partner in the previous 2 months, and
unmarried and not cohabiting. The model for
men was based on Surinam or Antillean origin
and painful micturition. No significant interac-
tions were found for either model. ROC curves
for both models are shown in figure 1.
No eVect of inclusion of the level of general
practice was observed in the multilevel analysis
(data not shown). Therefore, no further
random eVects models were considered.
VALIDATION OF THE SCREENING CRITERIA
(VALIDATION GROUP)
Application of the criteria for women yielded
an AUC of 0.58 (0.54–0.61); by screening 335
of the 662 women (51%), 12 of the 19 cases
(63%) were detected. The prevalence among
screened women was 3.6%. The AUC of the
selective criteria for men in the validation
group was 0.53 (0.48–0.57); by screening 10%
of the men (45/438), 15% of the cases (2/13)
were detected. The prevalence among screened
men was 4.4%.
Discussion
PARTICIPATION AND PREVALENCE
The prevalence of asymptomatic chlamydia
infections among men and women in Amster-
dam was less than 3%. For women the rate is
consistent with the prevalence found in a study
among sexually active women in inner city
London.9 Several opportunistic screening pro-
grammes have found higher prevalences.11–13
However, screening people who attend an STD
clinic, a family planning clinic or other primary
care clinic, probably overestimates the preva-
lence in the population as a whole. The highest
prevalences in this study were found among
men and women aged 21–25 years, the lowest
prevalences among people aged 15–20 years.
The prevalences found in the latter age
category are similar to prevalences found in a
study among high school children in
Antwerp.19 Other studies have found that high-
est prevalences occur among people aged
15–19 years. However, these studies were
mostly opportunistic screening programmes
targeted specifically at sexually active people.
In our study we found that 40% of men and
women aged 15–20 years had never been sexu-
ally active. These people should not be
excluded when calculating the prevalence in
the general population.
The participation rates found in the present
study were of 33% for men and 51% for
women. Similar rates have been reported in
another study based on mailed home obtained
samples.20 Strictly speaking participation rates
are higher since at least 18% of the non-
participants no longer lived at the registered
address at the start of the study. The number of
ghost patients could be as high as 32%, the
percentage of ghost patients reported in a
recent study in Bristol.21 The participation rate
in that study was 57%, 82% taking into
account the ghost patients and non-
responders, after two postal contacts, a tele-
phone call, and a home visit.
The use of telephone reminders and home
visits could have potentially increased the par-
ticipation rate in the current study. However,
these were considered an unnecessary invasion
of privacy by the medical ethics committee,
since the programme was an unsolicited
screening for healthy males and females. Direct
(telephone) contact between researchers and
participants was not allowed, except when
requested by the participant. Participants were
compared with non-participants on several
demographic variables. Participants were
found to be similar to non-participants with
regard to marital status, type of health
insurance, and age. However, participants were
more likely than non-participants to be of
Dutch origin. This may be due to cultural or
Table 4 Determinants found to be associated with Chlamydia trachomatis infections in men and women in the
development group (75% of all participants) by stepwise logistic regressions analysis
Determinants included in the model OR AUC [95% CI]
Sensitivity
(%)
% of total
population
screened
Prevalence in
screened
population (%)
Female model Surinam or Antillean origin 2.10 0.67 [0.65–0.69] 78* 52 4.4
Unmarried and not cohabiting 2.26
New sex partner previous 2 months 2.44
Male model Surinam or Antillean origin 3.01 0.58 [0.55–0.60] 26† 12 5.4
Painful micturition 3.04
*The cut oV value for men is a predicted probability >1%.
†The cut oV value for women is a predicted probability >2%.
“% of total population screened” is the true positive fraction + the false positive fraction, “prevalence in screened population” is the
predictive value positive, OR = odds ratio, CI = confidence interval, AUC = area under the curve, a measure of diagnostic accuracy.
Figure 1 Receiver operator characteristic curves of
selective screening criteria for men and women in the
development group (75% of participants). Female model:
Surinam of Antillean origin, unmarried and not
cohabiting. New sex partner in previous 2 months
(AUC=0.67).Male model: Surinam or Antillean
background, painful micturition (AUC=0.58). AUC=area
under the curve.
1 – Specificity
S
en
si
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language barriers, although information mate-
rial for the study was provided in the four most
relevant languages in Amsterdam. Participa-
tion rates were lowest among people with a
Turkish/Moroccan origin, a group with a rela-
tively low prevalence. There is no information
available on other determinants of infection
among non-participants, such as sexual risk
behaviour.
The determination of the prevalence esti-
mate could also have been aVected by the
quality of the test applied. Infections may have
been missed because the sensitivity of the LCR
on urine is less than 100%.6 On the other hand,
even though the specificity has been estimated
to be approximately 99% in some studies, in a
low prevalence population a considerable
percentage of the positive test results could be
false positives. In this study we used the LCR
test on urine for both men and women. Other
tests for C trachomatis detection are available,
such as TMA and PCR Cobas. It is not clear
how the choice of the method would have
influenced the results, since evaluation studies
do not clearly demonstrate which test is
superior.22 23 For women other samples besides
urine (for example, vaginal flush and vaginal
swabs) have also been evaluated.7 24 These
specimens have been shown to be more
sensitive than urine for C trachomatis detection.
In future programmes these should be consid-
ered as a suitable alternative for urine.
SELECTIVE SCREENING CRITERIA
In contrast with studies carried out in other
settings, age was found to be a poor predictor
of infection in this study, even though people
who had never been sexually active were
excluded in the evaluation of screening criteria.
The selective screening strategy for women in
this study was based on Surinam or Antillean
origin, unmarried and not cohabiting, and a
new sex partner in the previous 2 months.
However, the diagnostic accuracy of the
criteria was, at best, moderate. Furthermore,
application of the criteria to the validation
group showed even poorer diagnostic accuracy,
suggesting that in practice selection based on
simple criteria is not adequate to distinguish
clearly between infected and non-infected
women in the general population.
This is thought to be the first study to evalu-
ate selective criteria for men. In this study,
screening men who were of Surinam or
Antillean origin and reported painful micturi-
tion, identified a subgroup with a prevalence of
5.4%. The criteria, however, would not be
suitable for selective screening, since 75% or
more of all cases in the population would
remain undetected.
The results suggest that an eVective selective
screening strategy for a low risk population of
men is diYcult to achieve, if not impossible.
In this study symptoms such as lower
abdominal pain for women and painful mictu-
rition for men were included in the develop-
ment of screening criteria for asymptomatic C
trachomatis infections. People who list these
complaints are, strictly speaking, not asympto-
matic. However, a large portion of the popula-
tion report least one symptom, even though
they do not recognise the symptom as a sign of
infection, do not consult a physician, and do
not believe themselves to be at risk of an infec-
tion (unpublished data). We believe that these
people should be included, since these infec-
tions would otherwise go undetected.
In conclusion, the prevalence of asympto-
matic C trachomatis infections in Amsterdam, as
detected in urine specimens was found to be
less than 3%. Given the importance of early
treatment to prevent complications, selective
screening has been suggested by others as an
eYcient strategy for screening in low prevalence
populations.9 In this study, no suitable selective
screening criteria for men and women in
general practice could be identified. However, if
screening of the general population through
general practice were initiated, a universal
approach would seem more appropriate.
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